RxDoctor Payments Data

Marvin Spann, MD

Plastic Surgery · Las Vegas, NVNPI 1407044399

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,732 of the $4,594 with a category attached, or 81.2%. 29 manufacturers reported payments, led by AbbVie at 41.2% of the total. Reporting peaked in 2024 at $1,079 and has fallen 57.7% since, to $456 in 2025.

$4,594in general payments, 2019–2025

Across 117 payments — averaging $39.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Mentor Worldwide LLC$317
  • Sientra, Inc.$281
  • Genentech USA, Inc.$239
  • Lilly USA, LLC$216
  • Sun Pharmaceutical Industries Inc.$180
  • plus $1K from 23 others

What the payments were for

  • Travel & lodging$76317%
  • Food & beverage$3,73281%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,594 in reported general payments places this provider in the 70th percentile of 34 plastic surgery providers in Nevada.

See all plastic surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$186,568
Medicare patients
68
Services billed
258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen47$615
Cephalexin39$306
Doxycycline Monohydrate20$228
Ciprofloxacin Hcl16$132
Ondansetron Hcl12$64

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →